Tier 2 — strong
Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men
The Journal of physiology
2020
598; 4; 731-754
Bibliography
- PubMed
- PMID 31710095
- DOI
- 10.1113/jp278752
- Funding
- Funding details are not specified in the accessible publication information.
- Competing interests
- A complete competing-interest declaration is not specified in the accessible publication information.
Study snapshot
| Design | Muscle-biopsy analysis of a randomized placebo-controlled trial |
|---|---|
| Model | Human participants |
| Sample | 40 men; muscle-imaging subset of 16 |
| Intervention | NR 1000 mg twice daily versus placebo |
| Duration | 12 weeks |
| Endpoints | Muscle mitochondrial respiration; content; morphology |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



